Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00057343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospectively Randomized, Phase III, Multicenter, Controlled Trial to Evaluate the Safety and Efficacy of the Zevalin Therapeutic Regimen Plus Rituxan Compared With Rituxan Alone in Patients With Relapsed or Refractory Follicular NHL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to provide treatment for patients who have relapsed NHL or refractory NHL, and to determine the effectiveness and safety of the Zevalin and Rituxan regimens or Rituxan therapy alone on your disease.
Study identification
- NCT ID
- NCT00057343
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Sep 12, 2006
Started 2003
United States locations
- U.S. sites
- 67
- U.S. states
- 30
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Bakersfield | California | — | — |
| Research Site | Concord | California | — | — |
| Research Site | Duarte | California | — | — |
| Research Site | Loma Linda | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Mission Viejo | California | — | — |
| Research Site | Newport Beach | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Sacramento | California | — | — |
| Biogen Idec Incorporated | San Diego | California | 92121 | — |
| Research Site | San Diego | California | — | — |
| Research Site | Santa Barbara | California | — | — |
| Research Site | Vallejo | California | — | — |
| Research Site | Farmington | Connecticut | — | — |
| Research Site | Newark | Delaware | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Lakeland | Florida | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Coeur d'Alene | Idaho | — | — |
| Research Site | Aurora | Illinois | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Evanston | Illinois | — | — |
| Research Site | Harvey | Illinois | — | — |
| Research Site | Maywood | Illinois | — | — |
| Research Site | Urbana | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Munster | Indiana | — | — |
| Research Site | Kansas City | Kansas | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Flint | Michigan | — | — |
| Research Site | Royal Oak | Michigan | — | — |
| Research Site | Saint Joseph | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Rochester | Minnesota | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | Tupelo | Mississippi | — | — |
| Research Site | Columbia | Missouri | — | — |
| Research Site | Kansas City | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Farmington | New Mexico | — | — |
| Research Site | Buffalo | New York | — | — |
| Research Site | Manhasset | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Bismarck | North Dakota | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | Temple | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Bremerton | Washington | — | — |
| Research Site | Morgantown | West Virginia | — | — |
| Research Site | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00057343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2006 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00057343 live on ClinicalTrials.gov.